Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The American Journal of Medicine
|
March 26, 2008
Update on pharmacologic options for smoking cessation treatment
Mitchell Nides
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
June 19, 2004
Smoking reduction in the Lung Health Study
John Hughes, Paula Lindgren, John Connett, et al.
Harm Reduction Journal
|
June 30, 2018
Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA
Christopher Russell, Neil McKeganey, Tiffany Dickson, et al.
Preventive Cardiology
|
March 31, 2007
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions
Mitchell Nides, Scott Leischow, Linda Sarna, et al.
BMC Clinical Pharmacology
|
October 10, 2007
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell)
Bertrand Dautzenberg, Mitchell Nides, Jean-Luc Kienzler, et al.
American Journal of Health Behavior
|
April 18, 2018
Nicotine Lozenges in the Relief of Behaviorally Provoked Craving
Mitchell Nides, Gilbert Marava Shanga, Amanda Bishop, et al.
Psychopharmacology
|
May 1, 2014
Comparison of nicotine oral soluble film and nicotine lozenge on efficacy in relief of smoking cue-provoked acute craving after a single dose of treatment in low dependence smokers
Daniel Du, Mitchell Nides, James Borders, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
April 13, 2021
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)
Mitchell Nides, Nancy A Rigotti, Neal Benowitz, et al.
Archives of Internal Medicine
|
August 16, 2006
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up
Mitchell Nides, Cheryl Oncken, David Gonzales, et al.
Archives of Internal Medicine
|
August 16, 2006
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation
Cheryl Oncken, David Gonzales, Mitchell Nides, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The American Journal of Medicine
|
March 26, 2008
Update on pharmacologic options for smoking cessation treatment
Mitchell Nides
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
June 19, 2004
Smoking reduction in the Lung Health Study
John Hughes, Paula Lindgren, John Connett, et al.
Harm Reduction Journal
|
June 30, 2018
Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA
Christopher Russell, Neil McKeganey, Tiffany Dickson, et al.
Preventive Cardiology
|
March 31, 2007
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions
Mitchell Nides, Scott Leischow, Linda Sarna, et al.
BMC Clinical Pharmacology
|
October 10, 2007
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell)
Bertrand Dautzenberg, Mitchell Nides, Jean-Luc Kienzler, et al.
American Journal of Health Behavior
|
April 18, 2018
Nicotine Lozenges in the Relief of Behaviorally Provoked Craving
Mitchell Nides, Gilbert Marava Shanga, Amanda Bishop, et al.
Psychopharmacology
|
May 1, 2014
Comparison of nicotine oral soluble film and nicotine lozenge on efficacy in relief of smoking cue-provoked acute craving after a single dose of treatment in low dependence smokers
Daniel Du, Mitchell Nides, James Borders, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
April 13, 2021
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)
Mitchell Nides, Nancy A Rigotti, Neal Benowitz, et al.
Archives of Internal Medicine
|
August 16, 2006
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up
Mitchell Nides, Cheryl Oncken, David Gonzales, et al.
Archives of Internal Medicine
|
August 16, 2006
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation
Cheryl Oncken, David Gonzales, Mitchell Nides, et al.
Page
of 2